Concepedia

Kang Jye Chou

KJ

Statistics

Publications

1

Citations

29

H-Index

1

Active since

2022

Affiliations

Revolution Medicines (United States)(Current)

Kang Jye Chou is an author at Revolution Medicines (United States) specializing in non-small cell lung cancer therapy, oncogenic signaling pathways, and oncology.

Publications per year

2022–2022

1

Publications

1

Abstract 3596: RM-036, a first-in-class, orally-bioavailable, Tri-Complex covalent KRASG12D(ON) inhibitor, drives profound anti-tumor activity in KRASG12D mutant tumor models

John E. Knox, Jingjing Jiang, G. Leslie Burnett et al. · Cancer Research · 2022 · 29 citations

Medicine, Oncology, Pharmacology +15

1–1 of 1